BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

941 related articles for article (PubMed ID: 11429225)

  • 1. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
    Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
    Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
    Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
    J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mantle irradiation alone for clinical stage I-II Hodgkin's disease: long-term follow-up and analysis of prognostic factors in 261 patients.
    Wirth A; Chao M; Corry J; Laidlaw C; Yuen K; Ryan G; Byram D; Davis S; Kiffer J; Quong G; Liew K
    J Clin Oncol; 1999 Jan; 17(1):230-40. PubMed ID: 10458238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
    Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience.
    Barton M; Boyages J; Crennan E; Davis S; Fisher RJ; Hook C; Johnson N; Joseph D; Khoo V; Liew KH; Morgan G; O'Brien P; Pendlebury S; Pratt G; Quong G; Roos DE; Thornton D; Trotter G; Walker Q; Wallington M
    Radiother Oncol; 1996 Apr; 39(1):1-7. PubMed ID: 8735487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a prospective trial of mantle irradiation alone for selected patients with early-stage Hodgkin's disease.
    Backstrand KH; Ng AK; Takvorian RW; Jones EL; Fisher DC; Molnar-Griffin BJ; Silver B; Tarbell NJ; Mauch PM
    J Clin Oncol; 2001 Feb; 19(3):736-41. PubMed ID: 11157025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subdiaphragmatic Hodgkin's disease: the University of Florida experience.
    Hull MC; Mendenhall NP; Colgan ME
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):161-6. PubMed ID: 11777634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation.
    Mauch P; Tarbell N; Weinstein H; Silver B; Goffman T; Osteen R; Zajac A; Coleman CN; Canellos G; Rosenthal D
    J Clin Oncol; 1988 Oct; 6(10):1576-83. PubMed ID: 3171625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial.
    Mauch PM; Canellos GP; Shulman LN; Silver B; Tarbell NJ; Come S; Rabin MS; Coleman CN
    J Clin Oncol; 1995 Apr; 13(4):947-52. PubMed ID: 7707123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease--an analysis of risk, management, and outcome.
    Tate DJ; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1239-44. PubMed ID: 7607947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.
    Shah AB; Hudson MM; Poquette CA; Luo X; Wilimas JA; Kun LE
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):867-77. PubMed ID: 10386644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's disease stages IA and IIA. A long-term follow-up study on the gains achieved by modern therapy.
    Zagars G; Rubin P
    Cancer; 1985 Oct; 56(8):1905-12. PubMed ID: 4027927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
    Zanini M; Viviani S; Santoro A; Soncini F; Bonfante V; Devizzi L; Villani F; Castellani MR; Negretti E; Zucali R
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):813-9. PubMed ID: 7525516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group.
    Shankar AG; Ashley S; Radford M; Barrett A; Wright D; Pinkerton CR
    J Clin Oncol; 1997 Jul; 15(7):2622-30. PubMed ID: 9215833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for early stage Hodgkin's disease: Australasian patterns of care. Australasian Radiation Oncology Lymphoma Group.
    Barton M; Boyages J; Crennan E; Davis S; Fisher RJ; Hook C; Johnson N; Joseph D; Liew KH; Morgan G
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):227-36. PubMed ID: 7836074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of a prospective trial of mantle irradiation alone for early-stage Hodgkin's disease.
    Ng AK; Li S; Neuberg D; Fisher DC; McMillan C; Silver B; Marcus KC; Stevenson MA; Mauch PM
    Ann Oncol; 2006 Nov; 17(11):1693-7. PubMed ID: 17018702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
    Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.